Anne-Marie Roque-Afonso is an expert in Virology at Hôpital Paul-Brousse (France). As of October 2026, ScienceLeadR ranks Anne-Marie Roque-Afonso in the top 1% of experts worldwide for Hepatitis. Anne-Marie Roque-Afonso has authored 286 publications, the most recent in 2024, and is an investigator in 4 clinical trials. SLR score: 764 (community average: 125). How the SLR is computed.

LeadR Profile

Anne-Marie Roque-Afonso Hôpital Paul-Brousse France
764 ScienceLeadR Reputation 764
Network Map

Virology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2024

Source: PubMed

Hôpital Paul-Brousse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 286

Citations

Citations: 8 725 1st author: 19 Last author: 40 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period.
PMID 39328418 — hepatitis, autoimmune, sars-cov-2, anemia, aplastic, incidence, liver, immune system diseases, viruses, therapeutics, severe acute respiratory syndrome-related coronavirus, hepatitis, child
Front Immunol20241
Evaluation of two commercial diagnostic methods for HHV-8 viral load assessment.
PMID 38827633 — genes, herpesvirus 8, human, viral load, real-time polymerase chain reaction
IJID Reg20241
Novel scores relevant to antimicrobial resistance and hospital-acquired infections developed with data from a multi-hospital consortium in the Parisian region of France.
PMID 37898407 — incidence, infections, cross infection, carbapenems, multiple chronic conditions
J Hosp Infect20232
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
PMID 38184654 — immunity, genes, genomics, covid-19
Genome Med20241
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients.
PMID 38077399 — blood, viral load, covid-19, pneumonia, immune system diseases, prospective studies, plasma
Front Immunol20234

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3
Phase 4 1

By status:

Unknown 3
Completed 1

By type:

Interventional 2
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 16

LeadR Networks

Main global connection map